標題: Titlebook: Cardiac Considerations in Chronic Lung Disease; Surya P. Bhatt Book 2020 Springer Nature Switzerland AG 2020 chronic lung disease.COPD.chr [打印本頁] 作者: Colossal 時間: 2025-3-21 17:27
書目名稱Cardiac Considerations in Chronic Lung Disease影響因子(影響力)
書目名稱Cardiac Considerations in Chronic Lung Disease影響因子(影響力)學科排名
書目名稱Cardiac Considerations in Chronic Lung Disease網(wǎng)絡公開度
書目名稱Cardiac Considerations in Chronic Lung Disease網(wǎng)絡公開度學科排名
書目名稱Cardiac Considerations in Chronic Lung Disease被引頻次
書目名稱Cardiac Considerations in Chronic Lung Disease被引頻次學科排名
書目名稱Cardiac Considerations in Chronic Lung Disease年度引用
書目名稱Cardiac Considerations in Chronic Lung Disease年度引用學科排名
書目名稱Cardiac Considerations in Chronic Lung Disease讀者反饋
書目名稱Cardiac Considerations in Chronic Lung Disease讀者反饋學科排名
作者: 神經(jīng) 時間: 2025-3-21 20:39
Lecture Notes in Physics Monographsnhibitors (ACEI), and anti-arrhythmics are also important considerations. Most prospective clinical trials evaluating the efficacy and safety of inhaled bronchodilators have not found a greater risk of cardiac events, however, patients with CVD are usually excluded. Conversely, retrospective studies作者: Obscure 時間: 2025-3-22 03:09
Medication Safety in Chronic Lung Disease with Cardiac Comorbidity,nhibitors (ACEI), and anti-arrhythmics are also important considerations. Most prospective clinical trials evaluating the efficacy and safety of inhaled bronchodilators have not found a greater risk of cardiac events, however, patients with CVD are usually excluded. Conversely, retrospective studies作者: DEAWL 時間: 2025-3-22 08:29
Pathophysiology of Cardiovascular Disease in Chronic Lung Disease,isk factors including smoking and socioeconomic status, there is now growing evidence to suggest potential causality between CLD and CVD rather than simple association. In this chapter, we will review the pathobiologic processes that may drive the development of CVD in patients with CLD.作者: AMEND 時間: 2025-3-22 10:28 作者: Digitalis 時間: 2025-3-22 16:51 作者: Digitalis 時間: 2025-3-22 19:09 作者: defuse 時間: 2025-3-22 22:41
Respiratory Medicinehttp://image.papertrans.cn/c/image/221748.jpg作者: dialect 時間: 2025-3-23 05:25
A. F. Vakakis,O. V. Gendelman,Y. S. LeeThe association between lung disease and cardiovascular disease later in life has been well described. Both obstructive and restrictive lung physiology as measured with spirometry have been associated with cardiovascular disease and poor health outcomes.作者: Indict 時間: 2025-3-23 07:13
Solid Mechanics and Its ApplicationsExercise intolerance is a hallmark of chronic lung and heart disease. Effort-related symptoms, particularly dyspnea, are key clinical outcomes leading to impaired quality of life and poor survival in these patients [1].作者: RADE 時間: 2025-3-23 09:47
Origins of Cardiopulmonary Disease in Early Life,The association between lung disease and cardiovascular disease later in life has been well described. Both obstructive and restrictive lung physiology as measured with spirometry have been associated with cardiovascular disease and poor health outcomes.作者: 虛構(gòu)的東西 時間: 2025-3-23 14:27 作者: 轉(zhuǎn)向 時間: 2025-3-23 21:39
Cardiac Considerations in Chronic Lung Disease978-3-030-43435-9Series ISSN 2197-7372 Series E-ISSN 2197-7380 作者: 混合 時間: 2025-3-24 00:49
https://doi.org/10.1007/978-1-4020-9130-8isk factors including smoking and socioeconomic status, there is now growing evidence to suggest potential causality between CLD and CVD rather than simple association. In this chapter, we will review the pathobiologic processes that may drive the development of CVD in patients with CLD.作者: 遷移 時間: 2025-3-24 04:16 作者: 退出可食用 時間: 2025-3-24 07:40 作者: Optimum 時間: 2025-3-24 10:51
https://doi.org/10.1007/978-3-030-43435-9chronic lung disease; COPD; chronic obstructive pulmonary disease; cardiovascular disease; CLD; CVD; heart作者: PATHY 時間: 2025-3-24 16:20 作者: thwart 時間: 2025-3-24 20:29 作者: flamboyant 時間: 2025-3-25 02:52
https://doi.org/10.1007/978-1-4020-9130-8orbid chronic lung disease (CLD) and cardiovascular disease (CVD) will be examined. Data on this intersection are limited and are found mostly in literature focused on asthma and chronic obstructive pulmonary disease (COPD). Interstitial lung disease (ILD) will not be included in this chapter as the作者: 痛恨 時間: 2025-3-25 03:41
https://doi.org/10.1007/978-1-4020-9130-8isk factors including smoking and socioeconomic status, there is now growing evidence to suggest potential causality between CLD and CVD rather than simple association. In this chapter, we will review the pathobiologic processes that may drive the development of CVD in patients with CLD.作者: 運動的我 時間: 2025-3-25 08:50
A. F. Vakakis,O. V. Gendelman,Y. S. Leehronic lung disease is complex, and mechanisms include pulmonary hypertension, hypoxia, neurohormonal alterations, metabolic perturbations, endothelial dysfunction, ischemia, and systemic inflammation. The right ventricle can develop adaptive or maladaptive responses to these processes, and varying 作者: 預定 時間: 2025-3-25 13:14
Solid Mechanics and Its Applicationsng mean pulmonary arterial pressure?>20?mmHg during right heart catheterization (RHC). The most common chronic lung conditions that cause PH are chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF), but PH can occur in the context of other parenchymal lung diseases in作者: 不要不誠實 時間: 2025-3-25 19:13
A. F. Vakakis,O. V. Gendelman,Y. S. Leehy, and magnetic resonance imaging. Further on, the role of cardiac imaging in chronic lung disease will be reviewed by cardiac disease entity: coronary artery disease, pulmonary hypertension, right ventricular dysfunction, left ventricular disease, and cerebrovascular and peripheral arterial diseas作者: auxiliary 時間: 2025-3-25 23:30
Solid Mechanics and Its Applicationsg work closely together to achieve these ends. Because the heart and lung share volume and pressures within the thorax, each system tends to alter the other, especially when there is preexisting heart or lung disease, or when challenged by rising demand. Cardiopulmonary interactions are mediated by 作者: FOLD 時間: 2025-3-26 04:08
Lecture Notes in Physics Monographsation efficacy and safety in these patients is complicated by interrelationships among aging, frequent healthcare encounters, polypharmacy, alterations in drug disposition related to heart disease, aerosol drug delivery, drug interactions, and heightened risks of adverse-effects. In addition to side作者: AV-node 時間: 2025-3-26 06:38
Lecture Notes in Physics Monographse organised according to specialty, this is a slight misnomer as the main benefits of both services occur via the systemic features of the conditions. There is therefore a need to consider how services are organised for patients to maximise benefit both in terms of access and in receiving a tailored作者: CARE 時間: 2025-3-26 10:53 作者: 鎮(zhèn)痛劑 時間: 2025-3-26 14:20
https://doi.org/10.1007/978-3-540-68430-5gement, and immunosuppressive strategies have resulted in better long-term post-transplant outcomes. However, careful candidate selection, including a thorough assessment of cardiac function, is essential for optimizing the likelihood of survival while awaiting transplantation, and improving the cha作者: 虛情假意 時間: 2025-3-26 18:00 作者: Fissure 時間: 2025-3-26 23:07 作者: BRINK 時間: 2025-3-27 04:12
Pathophysiology of Cardiovascular Disease in Chronic Lung Disease,isk factors including smoking and socioeconomic status, there is now growing evidence to suggest potential causality between CLD and CVD rather than simple association. In this chapter, we will review the pathobiologic processes that may drive the development of CVD in patients with CLD.作者: 改進 時間: 2025-3-27 08:01
Pathophysiology of Right Heart Disease in Chronic Lung Disease,hronic lung disease is complex, and mechanisms include pulmonary hypertension, hypoxia, neurohormonal alterations, metabolic perturbations, endothelial dysfunction, ischemia, and systemic inflammation. The right ventricle can develop adaptive or maladaptive responses to these processes, and varying 作者: 冰河期 時間: 2025-3-27 12:38
Pulmonary Hypertension Associated with Chronic Lung Diseases: Treatment Considerations,ng mean pulmonary arterial pressure?>20?mmHg during right heart catheterization (RHC). The most common chronic lung conditions that cause PH are chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF), but PH can occur in the context of other parenchymal lung diseases in作者: Heresy 時間: 2025-3-27 14:27 作者: Statins 時間: 2025-3-27 19:47
Physiology of Heart-Lung Interactions,g work closely together to achieve these ends. Because the heart and lung share volume and pressures within the thorax, each system tends to alter the other, especially when there is preexisting heart or lung disease, or when challenged by rising demand. Cardiopulmonary interactions are mediated by 作者: 暴行 時間: 2025-3-27 23:11
Medication Safety in Chronic Lung Disease with Cardiac Comorbidity,ation efficacy and safety in these patients is complicated by interrelationships among aging, frequent healthcare encounters, polypharmacy, alterations in drug disposition related to heart disease, aerosol drug delivery, drug interactions, and heightened risks of adverse-effects. In addition to side作者: Omnipotent 時間: 2025-3-28 02:23
Cardiovascular Co-Morbidity in Chronic Lung Disease: Exercise Training,e organised according to specialty, this is a slight misnomer as the main benefits of both services occur via the systemic features of the conditions. There is therefore a need to consider how services are organised for patients to maximise benefit both in terms of access and in receiving a tailored作者: 和音 時間: 2025-3-28 08:02 作者: Blasphemy 時間: 2025-3-28 13:04
Lung Transplantation for Chronic Lung Disease: Cardiac Considerations,gement, and immunosuppressive strategies have resulted in better long-term post-transplant outcomes. However, careful candidate selection, including a thorough assessment of cardiac function, is essential for optimizing the likelihood of survival while awaiting transplantation, and improving the cha作者: Calibrate 時間: 2025-3-28 17:48 作者: 格子架 時間: 2025-3-28 20:12 作者: 粘連 時間: 2025-3-29 00:13
https://doi.org/10.1007/978-1-4020-9130-8rature focused on asthma and chronic obstructive pulmonary disease (COPD). Interstitial lung disease (ILD) will not be included in this chapter as there are too few studies to allow meaningful conclusions to be drawn.作者: 惰性氣體 時間: 2025-3-29 03:06 作者: 壕溝 時間: 2025-3-29 11:02
Cardiovascular Comorbidity in Chronic Lung Disease: Epidemiology, Clinical Manifestations, and Diag presence of chronic lung disease.?A low index of suspicion should be maintained to evaluate for chronic lung or cardiovascular disease when one?of these is present, especially when symptoms and functional impairment is deemed to be out of proportion for the existing diagnosis. 作者: expeditious 時間: 2025-3-29 14:18 作者: 拋媚眼 時間: 2025-3-29 17:04
Physiology of Heart-Lung Interactions, other, especially when there is preexisting heart or lung disease, or when challenged by rising demand. Cardiopulmonary interactions are mediated by changes in pleural pressure (.), lung volume, and gas exchange, all explored in the sections to follow.作者: 預測 時間: 2025-3-29 22:53 作者: 借喻 時間: 2025-3-30 03:31
